Insider Transactions in Q1 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.79%
|
$4,292
$37.58 P/Share
|
|
Jan 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.49%
|
-
|
|
Jan 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.55%
|
-
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,305
-4.32%
|
$48,285
$37.5 P/Share
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,309
+9.87%
|
-
|
|
Jan 15
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,420
-34.99%
|
$237,540
$37.5 P/Share
|
|
Jan 15
2025
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,378
+48.64%
|
-
|
|
Jan 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.85%
|
-
|
|
Jan 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,103
-5.23%
|
$33,090
$30.55 P/Share
|
|
Jan 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,690
+6.16%
|
-
|
|
Jan 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,500
-4.14%
|
$45,000
$30.55 P/Share
|
|
Jan 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+3.57%
|
-
|
|
Jan 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-3.08%
|
$25,650
$30.55 P/Share
|
|
Jan 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+6.98%
|
-
|
|
Jan 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-2.13%
|
$36,990
$30.55 P/Share
|
|
Jan 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,006
+2.57%
|
-
|
|
Jan 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,387
-5.07%
|
$41,610
$30.55 P/Share
|
|
Jan 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,381
+6.0%
|
-
|
|
Jan 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,183
-3.3%
|
$35,490
$30.55 P/Share
|
|
Jan 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,595
+4.89%
|
-
|
|
Jan 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,309
-1.8%
|
$1,299,270
$30.55 P/Share
|
|
Jan 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
94,555
+3.78%
|
-
|
|
Jan 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,309
-1.88%
|
$1,299,270
$30.55 P/Share
|
|
Jan 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
94,555
+3.94%
|
-
|